Exercise training for lung transplant candidates and recipients: a systematic review by Hume, Emily et al.
Northumbria Research Link
Citation: Hume, Emily, Ward, Lesley, Wilkinson, Mick, Manifield, James, Clark, Stephen and Vogiatzis, 
Ioannis (2020) Exercise training for lung transplant candidates and recipients: a systematic review. 
European Respiratory Review, 29 (158). p. 200053. ISSN 0905-9180 
Published by: European Respiratory Society
URL: https://doi.org/10.1183/16000617.0053-2020 <https://doi.org/10.1183/16000617.0053-2020>
This  version  was  downloaded  from  Northumbria  Research  Link: 
http://nrl.northumbria.ac.uk/id/eprint/44638/
Northumbria University has developed Northumbria Research Link (NRL) to enable users to access 
the University’s research output. Copyright © and moral rights for items on NRL are retained by the 
individual author(s) and/or other copyright owners.  Single copies of full items can be reproduced, 
displayed or performed, and given to third parties in any format or medium for personal research or 
study, educational, or not-for-profit purposes without prior permission or charge, provided the authors, 
title and full bibliographic details are given, as well as a hyperlink and/or URL to the original metadata 
page. The content must not be changed in any way. Full items must not be sold commercially in any  
format or medium without formal permission of the copyright holder.  The full policy is available online: 
http://nrl.northumbria.ac.uk/pol  i cies.html  
This  document  may differ  from the  final,  published version of  the research  and has been made 
available online in accordance with publisher policies. To read and/or cite from the published version 
of the research, please visit the publisher’s website (a subscription may be required.)
                        

Exercise training for lung transplant
candidates and recipients: a systematic
review
Emily Hume1, Lesley Ward1, Mick Wilkinson1, James Manifield 1,
Stephen Clark1,2 and Ioannis Vogiatzis1
Affiliations: 1Dept of Sport, Exercise and Rehabilitation, Faculty of Life Sciences, Northumbria University,
Newcastle Upon Tyne, UK. 2Cardiothoracic Centre, Freeman Hospital, Newcastle upon Tyne, UK.
Correspondence: Ioannis Vogiatzis, Dept of Sport, Exercise and Rehabilitation, Faculty of Health and Life
Sciences, Northumbria University, Northumberland Building, Newcastle upon Tyne, NE1 8ST, UK. E-mail:
ioannis.vogiatzis@northumbria.ac.uk
@ERSpublications
Both inpatient and outpatient exercise training appears beneficial for improving exercise capacity and
quality of life in lung transplant candidates and recipients. Further research investigating the effect on
post-surgery clinical outcomes is required. https://bit.ly/2XD6J6S
Cite this article as: Hume E, Ward L, Wilkinson M, et al. Exercise training for lung transplant candidates
and recipients: a systematic review. Eur Respir Rev 2020; 29: 200053 [https://doi.org/10.1183/
16000617.0053-2020].
ABSTRACT Exercise intolerance and impaired quality of life (QoL) are characteristic of lung transplant
candidates and recipients. This review investigated the effects of exercise training on exercise capacity, QoL
and clinical outcomes in pre- and post-operative lung transplant patients. A systematic literature search
of PubMed, Nursing and Allied Health, Cochrane (CENTRAL), Scopus and CINAHL databases was
conducted from inception until February, 2020. The inclusion criteria were assessment of the impact of
exercise training before or after lung transplantation on exercise capacity, QoL or clinical outcomes.
21 studies met the inclusion criteria, comprising 1488 lung transplant candidates and 1108 recipients.
Studies consisted of five RCTs, two quasi-experimental and 14 single-arm cohort or pilot studies. Exercise
training improved or at least maintained exercise capacity and QoL before and after lung transplantation.
The impact on clinical outcomes was less clear but suggested a survival benefit. The quality of evidence
ranged from fair to excellent.
Exercise training appears to be beneficial for patients before and after lung transplantation; however, the
evidence for direct causation is limited by the lack of controlled trials. Well-designed RCTs are needed, as
well as further research into the effect of exercise training on important post-transplant clinical outcomes,
such as time to discharge, rejection, infection, survival and re-hospitalisation.
Introduction
Lung transplantation is a surgical procedure for selected patients with life-threatening, advanced lung
disease that is unresponsive to other medical or surgical treatments. The most common disease entities
resulting in lung transplantation include chronic obstructive pulmonary disease (COPD), cystic fibrosis
(CF), idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension [1]. Over recent years,
advances in organ preservation, immunosuppressant therapies, surgical techniques and peri-operative
management have led to gradual improvements in survival rates of transplantation surgery. The median
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survival rate of 5.8 years, nevertheless, still remains below that of other solid-organ transplants [2]. It is
well documented that the number of patients awaiting lung transplantation exceeds the number of suitable
donor organs available. As waiting list times can therefore be prolonged, averaging 326 days in the UK [3],
it is important to maintain functional capacity and prevent further physical deterioration in patients
awaiting lung transplantation [4].
In patients with advanced lung disease, several physiological factors negatively impact physical activity,
including ventilatory limitations, metabolic and gas exchange abnormalities, cardiovascular impairment
and peripheral muscle weakness [5]. Evidence indicates that functional capacity, as assessed through the
6-min walk test (6MWT), is reduced in patients awaiting lung transplantation compared to healthy
age-matched individuals. The 6MWT distance, therefore, constitutes an important predictor of mortality
[6, 7] and has been established as a predictor of post-transplant survival [8, 9]. A previous systematic
review [10], comprising two randomised controlled trials (RCTs), two quasi-experimental studies and two
retrospective studies concluded that pulmonary rehabilitation can be a beneficial treatment for improving
functional capacity and quality of life (QoL) in lung transplant candidates. Studies are, however, still
scarce, particularly RCTs. Notably, in the previous review [10], there were no studies looking at the effect
of pulmonary rehabilitation on important outcomes, such as survival.
Following lung transplantation, there is a marked improvement in pulmonary function. However, patients
still experience physical impairments, such as limited exercise capacity (40–60% of predicted normal
values), early-onset of metabolic acidosis and skeletal muscle weakness, all of which persist for years after
transplant surgery [11, 12]. In the early post-transplant phase, this is likely due to deconditioning from the
extended intensive care and hospital stay following surgery, which can vary from 3 to 6 weeks or more if
complications ensue. Additionally, immunosuppressant medications which are taken chronically following
lung transplantation are accompanied by several side effects, including adverse effects on the cellular
features of skeletal muscle [13]. Lung transplant patients also face a number of psychological stressors
throughout the course of the transplant journey, which can significantly impact QoL, physical functioning
and adherence to recovery regimes [14].
At 1 year post surgery, daily sedentary time remains significantly increased in lung transplant patients
compared to healthy individuals, with daily steps, standing time and walking time all significantly reduced
[15]. It has, therefore, been deemed necessary to implement therapeutic exercise protocols after lung
transplantation. Such studies (RCTs, controlled trials and prospective cohorts) have been presented in a
systematic review that was published in 2010 [16]. The overall quality of these studies was deemed fair to
moderate and positive outcomes were indicated in areas of maximal and functional exercise capacity,
skeletal muscle function and lumbar bone mineral density. Since the previous systematic reviews [10, 16],
there have been several new studies investigating the effect of exercise therapy protocols before [17–21]
and after [22–30] lung transplantation.
The American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation [31]
highlights the need to understand the mechanisms of improvement in functional capacity and QoL
following pulmonary rehabilitation interventions in lung transplant candidates and recipients. Accordingly,
the aim of the present systematic review is to investigate the effects of exercise training before and after
lung transplantation on exercise capacity, QoL and clinical outcomes (including survival, length of hospital
or intensive care unit (ICU) stay, hospitalisations). Additionally, the safety of exercise training protocols in
this patient population will be evaluated.
Methods
Protocol and registration
This systematic review was conducted in accordance with the guidelines for the Preferred Reporting Items
for Systematic Reviews and Meta-Analyses (PRISMA) [32]. The review protocol is registered in the
International Prospective Register of Systematic Reviews (PROSPERO ID: CRD42020166322).
Search strategy
PubMed, Cochrane Central Register of Controlled Trials (CENTRAL), Nursing and Allied Health, Scopus,
and CINAHL databases were searched from inception until February 2020. These six databases were chosen
due to their relevance in clinical research and use in related systematic reviews [10, 16]. Database-specific
search strategies, developed and pilot tested in consultation with a senior librarian, were based on keywords
and MeSH terms related to “lung transplantation”, “exercise”, “rehabilitation”, “exercise capacity”, “quality of
life” and “survival”. Full details of the PubMed search strategy are detailed in supplementary material. The
reference lists of all relevant systematic reviews identified in the search were also screened for additional
studies. The search was restricted to peer-reviewed studies written in English, as access to a translator was
not available. All search results were collated using EndNote software (Thomson Reuters, New York, NY,
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USA) and duplicates removed. Remaining references were exported to the systematic review management
software program Rayyan (Qatar Computing Research Institute, Doha, Qatar).
Inclusion criteria
The titles and abstracts were reviewed independently by two authors (E. Hume and J. Manifield) to
determine if the studies met the pre-determined PICOS (population, intervention, comparators, outcomes
and study design) criteria as follows. Population: lung transplant candidates or recipients (>18 years old)
with any lung disease; intervention: studies evaluating the effects of an exercise training intervention. This
was defined as all planned, structured and repetitive physical activity that had a final or an intermediate
objective of improving or maintaining physical fitness [33]; comparator: no exercise control group, an
active control group or a different dose/mode/setting of exercise training were considered acceptable
controls in RCTs; outcomes: exercise capacity (assessed through 6MWT, incremental shuttle walk test
(ISWT), endurance shuttle walk test (ESWT) or cardiopulmonary exercise testing (CPET)), QoL
(including health-related QoL (HRQoL)) and psychological health, assessed through generic or
respiratory-specific questionnaires), clinical outcomes (survival, hospitalisations, length of hospital or ICU
stay); design: studies of all design type were included, as evidence suggests that non-randomised
intervention studies, including observational study designs, are key to many areas of healthcare evaluation
and can provide complementary evidence to RCTs [34].
Screening of full texts was performed by two independent reviewers (E. Hume and J. Manifield) and the
reasons for exclusion of ineligible studies was recorded. Any disagreements were resolved through
consultation with a third reviewer (I. Vogiatzis).
Data extraction and synthesis
Data extraction was performed by a single author (E. Hume) using a predesigned, standardised Excel
(Microsoft, Redmond, WA, USA) form. The following study characteristics were extracted: author
information (including name of first author and year of publication), participant characteristics (number,
mean age, sex, baseline lung function), study design, setting (country, inpatient, outpatient or home based)
interventions details, outcome measures (exercise capacity, QoL and clinical outcomes) and effect sizes for
post-intervention differences between intervention and control/comparison groups (RCT and
non-randomised controlled trials), or pre- to post-intervention differences (cohort and pilot studies).
Effect size was expressed as Cohen’s d using the mean difference and pooled standard deviation [35].
Meta-analyses were planned if three or more studies with clinical and methodological homogeneity were
identified [36]. For questionnaires with subscales, only those reporting composite scores were extracted, to
give a clearer picture of the efficacy of one therapeutic approach versus another [37].
Quality assessment
The methodological quality of the studies was evaluated using the Downs and Black checklist [38],
designed to assess both randomised and non-randomised study designs. The checklist comprises 27
questions under four sub-scales of reporting, external validity, internal validity (bias and confounding) and
power. Each question was scored out of 1, except for question five, which was scored out of 2, with a
maximum total score of 28. Scoring of the last item (study power) was modified from a 0–5 scale to a 0–1
scale, where 1 was scored if a sample size/power calculation was present, while 0 was scored if there was
no power/sample size calculation or explanation whether the number of subjects was appropriate [38, 39].
A score of 24–28 points was considered excellent, 19–23 good, 14–18 fair and <14 poor, in terms of
methodological quality [40]. Each study was scored independently by two authors (E. Hume and
J. Manifield), with discrepancies resolved through consensus.
Results
A total of 1962 articles were yielded from the six database searches, of which, 393 records were duplicates.
Following screening of titles and abstracts, 47 articles remained for full text screening. On completion of full
text screening, 21 studies met the eligibility criteria and were included in the review. A PRISMA flow
diagram of the screening process is presented in figure 1. Due to heterogeneity in study designs,
interventions, comparison groups and outcome measures, quantitative synthesis via meta-analysis was not
performed, as pooling the data would have led to misleading results that were not clinically meaningful [41].
Study characteristics and interventions
The characteristics of the included studies are presented in table 1.
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Pre-transplant
Nine of the 21 studies involved pre-transplant patients (n=1488), with a mean age of 52 years (range 37–
63 years) and average forced expiratory volume in 1 s (FEV1) % predicted range of 26 to 54%. Between 43
and 95% (median=58%) of participants in each study were male. Of the pre-transplant studies, there was
one RCT [42], two quasi-experimental [17, 18], five cohort studies [19, 20, 43–45] and one single-arm
pilot study [21]. Eight of the nine studies implemented both aerobic and resistance exercise [17, 19–21,
42–45] and one study included Nordic walking only [18]. Two studies were conducted as inpatient
programmes [42, 44], four were outpatient exercise programmes [17, 19, 43, 45], two combined outpatient
and home-based training [18, 20], and one was home-based using an online application [21]. The length
of exercise training ranged from 3 to 16 weeks, with exercise session frequency ranging from two to six
exercise sessions per week.
Post-transplant
Twelve studies involved exercise training with post-transplant populations. These studies included 1108
recipients of either single or bilateral lung transplant, with a mean age of 52 years (range 44–59 years), and
average FEV1 % predicted ranging from 64 to 75%. Between 47 and 98% (median=56%) of participants in
each study were male. Included studies comprised four RCTs [22–24, 30], five cohort studies [25, 26, 46–48]
and two single-arm pilot studies [27, 29]. A further, controlled trial by VIVODTZEV et al. [28] used healthy
individuals as a control group; therefore, only the outcomes reported for lung transplant recipients were
included in this review. One RCT compared the effect of exercise training to an active control group
(physical activity counselling) [22], one compared an inpatient programme with outpatient physiotherapy
[23], one compared different durations of supervised exercise training [24] and one compared exercise
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FIGURE 1 PRISMA flow diagram for database search and study selection process.
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TABLE 1 Characteristics of included studies
First author [ref.] Setting Sample Study design
Duration and
frequency Intervention Comparison
Outcomes
1) Exercise capacity
2) QoL
3) Clinical outcomes
Pre-transplant
GLOECKL et al.
[42]
Germany: supervised
inpatient programme
Sample size: 60
Mean age years: 53±6
Sex: 47% male
FEV1 % pred: 25±8
RCT 3 weeks
5–6× per week
Exercise programme.
Interval training:
30 s cycling
alternating with 30 s
rest. Resistance
exercises.
Exercise programme.
Continuous training:
cycling (60% PWR).
Resistance
exercises.
1) 6MWT, PWR
2) SF-36
3) Not assessed
FLORIAN et al. [17] Brazil: supervised
outpatient programme
Sample size: 89
Mean age years: 56±11
Sex: 64% male
FEV1 % pred: 46±15
Quasi-experimental 12 weeks (36 sessions)
3× per week
Exercise programme.
Aerobic exercises:
treadmill walking.
Resistance: arm and
leg exercises.
Breathing exercises
associated with arm
raising.
Patients not
completing 36
sessions
1) 6MWT
2) SF-36
3) Survival rate, LOS in
hospital and ICU,
IMV
OCHMAN et al. [18] Poland: outpatient and
home-based
programme
Sample size: 40
Mean age years:
Intervention: 50±8
Control: 54±9
Sex: 95% male
FEV1 % pred:
Intervention: 39±20.5
Control: 43±22.2
Quasi-experimental 12 weeks Exercise programme.
Nordic walking
No treatment control
group
1) 6MWT
2) SF-36
3) Not assessed
FLORIAN et al. [43] Brazil: supervised
outpatient programme
Sample size: 58
Mean age years: 46±14
Sex: 48% male
FEV1 % pred: 33±16
Cohort study 12 weeks
3× per week
(36 sessions)
Exercise programme.
Aerobic exercises:
treadmill walking.
Resistance: arm and
leg exercises.
Breathing exercises
associated with arm
raising. Stretching:
major muscle
groups.
None 1) 6MWT
2) SF-36
3) Not assessed
DA FONTOURA et al.
[19]
Brazil: supervised
outpatient programme
Sample size: 31
Mean age years: 57±10
Sex: 58% male
FEV1 % pred: 54±16
Cohort study 12 weeks
3× per week
Exercise programme.
Aerobic exercise:
treadmill.
Resistance exercise:
upper and lower
body (light weights
and resistance
bands).
None 1) 6MWT
2) SF-36
3) Not assessed
Continued
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TABLE 1 Continued
First author [ref.] Setting Sample Study design
Duration and
frequency Intervention Comparison
Outcomes
1) Exercise capacity
2) QoL
3) Clinical outcomes
KENN et al. [44] Germany: supervised
inpatient programme
Sample size: 811
Mean age years:
COPD male: 54±7.6
COPD female: 54±7.4
AATD male: 51±6.3
AATD female: 52±8.2
ILD male: 54±8.7
ILD female: 53±7.9
CF male: 31±7.4
CF female: 31±8.6
Other male: 45±12.9
Other female: 45±11.3
Sex: 43% male
FEV1 % pred:
COPD male: 25.2±12.6
COPD female: 25.5±7.6
AATD male: 25.6±9.2
AATD female: 27.2±8.9
ILD male: 49.2±19.5
ILD female: 43.5±16.4
CF male: 23.8±7.8
CF female: 26.2±7.7
Other male: 33.5±15.2
Other female: 33.2±20.5
Cohort study 5–6 weeks
5–6× per week (25–
30 sessions)
Exercise programme.
Aerobic exercise:
cycle ergometer.
Resistance training.
Breathing exercises.
Controlled coughing
exercises.
None 1) 6MWT
2) SF-36
3) Not assessed
LI et al. [45] Canada: supervised
outpatient programme
Sample size: 345
Mean age years: 51±14
Gender: 55% male
FEV1 % pred: Not stated
Cohort study 47±59 sessions
3× per week
Exercise programme.
Aerobic exercise:
arm ergometer,
cycle ergometer and
treadmill;
Stretching and
resistance training:
biceps, triceps,
quadriceps,
hamstrings and hip
muscles.
None 1) 6MWT
2) SF-36, SGRQ, VAS,
Standard Gamble,
EQ5Q
3) Discharge
disposition, hospital
and ICU LOS,
intubation days
Continued
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TABLE 1 Continued
First author [ref.] Setting Sample Study design
Duration and
frequency Intervention Comparison
Outcomes
1) Exercise capacity
2) QoL
3) Clinical outcomes
PEHLIVAN et al.
[20]
Turkey: supervised
outpatient and
home-based
programme
Sample size: 39
Mean age: 37±13
Sex: 64% male
FEV1 % pred: 26±11
Cohort study 8 weeks (minimum)
5× per week (2
supervised, 3 at
home)
Exercise programme.
Aerobic exercise:
cycle ergometer,
treadmill walking,
arm ergometer.
Resistance
exercises. Home
exercises: breathing
exercises,
strengthening
exercises using
Thera-bands,
walking.
None 1) 6MWT
2) SF-36, BDI
3) Not assessed
SINGER et al. [21] USA: home-based
programme using app
Sample size: 15
Mean age years: 63±6
Sex: 67% male
FEV1 % pred: 42±26
Pilot Study 8 weeks Exercise programme.
Home-based
exercise using
Aidcube App.
Aerobic exercise:
treadmill or ground
walking. Resistance
exercises:
Thera-bands.
None 1) 6MWT
2) Not assessed
3) Not assessed
Post-transplant
LANGER et al. [22] Belgium: supervised
outpatient programme
Sample size: 36
Mean age years: 59±6
Sex: 50% male
FEV1 % pred:
Intervention: 79±18
Control: 69±17
RCT 12 weeks
3× per week
Exercise programme.
Aerobic exercises:
cycling, walking,
stair climbing.
Resistance
exercises: leg press
equipment.
Physical activity
counselling.
6 sessions, 15–
30 mins
1) 6MWT (% pred),
VO2peak (% pred),
PWR (% pred)
2) SF-36 and HADS
3) Not assessed
IHLE et al. [23] Germany: supervised
inpatient programme
Sample size: 60
Mean age years:
Intervention=49±14
Control=50±12
Sex: 57% male
FEV1 % pred: Not
reported
RCT 23±5 days Inpatient exercise
programme.
Endurance training.
Resistance training:
upper and lower
limb. Stretching:
major muscle
groups.
Range-of-motion
exercises: neck,
shoulders and
trunk.
Outpatient
physiotherapy.
Cardiovascular
exercise, airway
clearance and
breathing exercises.
1) 6MWT, PWR, VO2peak
2) SF-36, SGRQ
3) Not assessed
Continued
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TABLE 1 Continued
First author [ref.] Setting Sample Study design
Duration and
frequency Intervention Comparison
Outcomes
1) Exercise capacity
2) QoL
3) Clinical outcomes
FULLER et al. [24] Australia: supervised
outpatient programme
and home-based
unsupervised
programme
Sample size: 66
Mean age years: 51±13
Sex: 50% male
FEV1 % pred:
Intervention: 70±21
Control: 69±23
RCT 14 weeks
3× per week
Exercise programme.
14 weeks
supervised.
Aerobic training:
treadmill and cycle
ergometer.
Resistance training:
upper and lower
limb. Functional
exercises and core
stability.
Exercise programme.
7 weeks supervised
7 weeks
home-based.
Aerobic training:
treadmill and cycle
ergometer.
Resistance training:
upper and lower
limb. Functional
exercises and core
stability.
1) 6MWT
2) SF-36
3) Not assessed
GLOECKL et al.
[30]
Germany: inpatient
programme
Sample size: 80
Mean age years: 56±7
Sex: 53% male
FEV1 % pred: 68±20
RCT 4 weeks
5–6× per week
Exercise programme
with WBVT.
Aerobic exercise:
cycle ergometer.
Resistance
exercises: major
muscle groups
+WBVT squats.
Exercise programme.
Aerobic exercise:
cycle ergometer.
Resistance
exercises: major
muscle groups.
1) 6MWT, PWR
2) HADS, CRQ
3) Not assessed
CANDEMIR et al.
[25]
Turkey: outpatient
programme (two
sessions supervised,
one unsupervised)
Sample size: 23
Mean age years: 47±10
Sex: 88% male
FEV1 % pred: 75±15
Cohort study 12 weeks Exercise programme.
Aerobic exercise:
treadmill, cycle
ergometer.
Resistance exercise:
lower and upper
extremities
None 1) ISWT and ESWT
2) SGRQ, CRQ and
HADS
3) Not assessed
MUNRO et al. [46] Australia: supervised
outpatient programme
Sample size: 36
Mean age years: 46±14
Sex: 50% male
FEV1 % pred: 71±18
Cohort study 12 weeks
3× per week
Exercise programme.
Aerobic exercises:
cycling, treadmill
walking. Resistance
training: upper and
lower limb.
Stretching: major
muscle groups
None 1) 6MWT
2) SF-36
3) Not assessed
MAURY et al. [47] Belgium: supervised
outpatient programme
Sample size: 36
Mean age years: 57±4
Sex: 47% male
FEV1 % pred: 70±21
Cohort study 12 weeks
3× per week
Exercise programme.
Aerobic exercises:
cycling, walking,
stair climbing.
Resistance
exercises:
quadriceps muscle.
None 1) 6MWT
2) Not assessed
3) Not assessed
Continued
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TABLE 1 Continued
First author [ref.] Setting Sample Study design
Duration and
frequency Intervention Comparison
Outcomes
1) Exercise capacity
2) QoL
3) Clinical outcomes
STIEBELLEHNER
et al. [48]
Austria: supervised
outpatient programme
Sample size: 9
Mean age years: 44±6
Sex: 67% male
FEV1 % pred: 65±17
Cohort study 6 weeks
3–5× per week
Exercise programme.
Aerobic exercise:
cycle ergometer
None 1) VO2peak
2) Not assessed
3) Not assessed
SCHNEEBERGER
et al. [26]
Germany: supervised
inpatient programme
Sample size: 722
Mean age years:
COPD SLTx: 59±5
COPD DLTx 54±7
ILD SLTx: 58±7
ILD DLTx: 54±9
Sex: 55% male
FEV1 % pred:
COPD SLTx: 51.1±16.6
COPD DLTx: 73.7±20.1
ILD SLTx: 60.2±18.9
ILD DLTx: 65.6±18.1
Cohort study 6 weeks
5–6× per week
Exercise programme.
Aerobic training:
cycle ergometer.
Resistance training:
lower extremities.
Breathing exercises.
Activities of daily
living: stair
climbing.
None 1) 6MWT
2) SF-36
3) Not assessed
ANDRIANOPOULOS
et al. [27]
Germany: supervised
inpatient programme
Sample size: 24
Mean age years: 58±6
Sex: 58% male
FEV1 % pred: 75.4±22
Pilot study 3 weeks
5–6× per week
(15 sessions
minimum)
Exercise programme.
Aerobic training:
cycle ergometer.
Resistance training:
upper and lower
limb. Activities of
daily living training:
walking and/or
calisthenics
exercises.
None 1) 6MWT
2) Not assessed
3) Not assessed
CHOI et al. [29] USA: home programme
using computer
program
Sample size: 4
Mean age years: 55±17
Sex: 75% male
FEV1 % pred: 71.3±25.2
Pilot study 8 weeks
8 sessions
Exercise programme.
Aerobic exercise:
walking. Resistance
exercises: cuff
weights. Balance
exercises.
None 1) 6MWT
2) Not assessed
3) Not assessed
VIVODTZEV et al.
[28]
France: home programme
(supervised via phone)
Sample size: 12
Mean age years: 47±13
Sex: 83% male
FEV1 % pred: 74±24
Controlled trial
(healthy controls)
12 weeks
3× per week
Exercise programme.
Aerobic exercise:
cycle ergometer.
None 1) VO2peak, endurance
time
2) Not assessed
3) Not assessed
Data are presented as mean±SD, unless otherwise stated. FEV1: forced expiratory volume in 1 s; COPD: chronic obstructive pulmonary disease; ILD: interstitial lung disease; CF: cystic
fibrosis; AATD: α1-antitrypsin deficiency; SLTx: single lung transplant; DLTx: double lung transplant; RCT: randomised controlled trial; QoL: quality of life; 6MWT: 6-min walk test; VO2peak:
peak oxygen uptake; PWR: peak work rate; ISWT: incremental shuttle walk test; ESWT: endurance shuttle walk test; SF-36: Short Form 36 Questionnaire; SGRQ: St George’s Respiratory
Questionnaire; CRQ: Chronic Respiratory Questionnaire; HADS: Hospital Anxiety and Depression Scale; VAS: Visual Analogue Scale; BDI: Beck Depression Inventory; Hospital LOS:
hospital length of stay; ICU LOS: intensive care unit length of stay; IMV: invasive mechanical ventilation; WBVT: whole body vibration training.
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training with whole body vibration training (WBVT) to exercise training alone [30]. Ten of the 12 studies
implemented exercise programmes comprising both aerobic and resistance exercise [22–27, 29, 30, 46, 47]
and two comprised aerobic training only [28, 48]. Four studies implemented inpatient programmes [23, 26,
27, 30], five were outpatient programmes [22, 25, 46–48] and two were home based [28, 29]. The length of
training varied from 3 to 14 weeks, with session frequency ranging from three to six times a week.
Quality assessment
Quality assessment ratings, using Downs and Black, are presented in table 2. The mean score for the 21
included studies was 18 out of a possible 28 (range 14 to 25), indicating fair to excellent methodological
quality. The RCTs scored highest for methodological quality. Across studies, scoring was low for item 8
(reporting of adverse events), item 12 (representative sample), item 14 (blinding of subjects), item 15
(blinding of assessors) and item 27 (sample size). Poor scoring for item 14 was expected, as it is difficult
to blind patients from the condition they are receiving, due to the nature of the intervention. The
methodological quality of the non-randomised and cohort studies was limited because of non-random
allocation and lack of control for confounding variables.
Exercise capacity outcomes
The measures of exercise capacity pre- and post-exercise intervention are presented in table 3.
Pre-transplant
All nine pre-transplant studies in the review assessed functional exercise capacity using the 6MWT, with
seven of the nine studies reporting a significant improvement in this outcome after exercise training. In
addition to the 6MWT, GLOECKL et al. [42] also assessed peak work rate (PWR) during an incremental test,
and found that both interval and continuous training significantly improved both measures of exercise
capacity, with no difference in the magnitude of improvement between groups. FLORIAN et al. [17] reported
a significant increase in 6MWT distance in the exercise training group; however, no 6MWT data were
presented for the control group. Nordic walking elicited a significant improvement in 6MWT distance
compared with a control group after 12 weeks [18]. Of the five cohort studies, four showed significant
improvements in 6MWT distance following combined aerobic and resistance training [19, 20, 43, 44].
TABLE 2 Downs and Black Methodological Quality Assessment
First author [ref.]
Reporting
(out of 11)
External validity
(out of 3)
Internal validity:
bias (out of 7)
Internal validity:
confounding (out of 6)
Power
(out of 1)
Total score
(out of 28)
Pre-transplant
GLOECKL et al. [42] 11 2 5 6 1 25
FLORIAN et al. [17] 8 2 5 4 0 19
OCHMAN et al. [18] 7 1 4 3 0 15
FLORIAN et al. [43] 8 3 5 3 0 19
DA FONTOURA et al. [19] 8 2 5 2 0 17
KENN et al. [44] 8 2 5 3 0 18
LI et al. [45] 7 2 3 3 0 15
PEHLIVAN et al. [20] 8 1 5 3 0 17
SINGER et al. [21] 9 3 5 3 0 20
Post-transplant
LANGER et al. [22] 9 2 6 6 1 24
IHLE et al. [23] 9 2 5 5 0 21
FULLER et al. [24] 11 2 6 5 1 25
GLOECKL et al. [30] 10 2 6 4 1 23
CANDEMIR et al. [25] 8 1 5 3 0 17
MUNRO et al. [46] 7 3 4 3 0 17
MAURY et al. [47] 7 2 4 3 0 16
STIEBELLEHNER et al. [48] 7 1 5 2 0 15
SCHNEEBERGER et al. [26] 9 1 5 2 0 17
ANDRIANOPOULOS et al. [27] 8 1 5 2 0 16
CHOI et al. [29] 7 1 4 2 0 14
VIVODTZEV et al. [28] 7 1 5 1 0 14
Cut-off points of the summative score are: excellent (24–28), good, (19–23), fair (14–18), and poor (<14).
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TABLE 3 Effects of pre- and post-transplant exercise training interventions on measures of exercise capacity
First author [ref.] N Duration Measure Intervention/comparison
Δ (mean±SD where
reported)
Pre–post
p-value
Between group
p-value Effect size
Pre-transplant
GLOECKL et al. [42] 60 3 weeks 6MWT (m) Interval ET 35.4±28.9 p<0.05 p=0.89 INT<CON;
0.0008
Continuous ET 35.7±42.2 p<0.05
PWR (W) Interval ET 12.0±8.5 p<0.05 p=0.38 INT>CON; 0.29
Continuous ET 9.3±10.1 p<0.05
FLORIAN et al. [17] 89 12 weeks 6MWT (m) ET 43±86 p=0.005 - PRE<POST; 0.5
Control NR NR - -
OCHMAN et al. [18] 40 12 weeks 6MWT (m) Nordic walking ET 64 p=0.0378 p=0.034 UTC
Control −57 p=0.0059
PEHLIVAN et al. [20] 39 8 weeks 6MWT (m) ET 54.3 p=0.001 - PRE<POST; 0.49
FLORIAN et al. [43] 58 12 weeks 6MWT (m) ET 72 p=0.001 - PRE<POST; 0.57
DA FONTOURA et al. [19] 31 12 weeks 6MWT (m) ET 58±63 p<0.001 - PRE<POST; 0.92
KENN et al. [44] 811 5–6 weeks 6MWT (m) ET 55.9±58.5 p<0.001 - PRE<POST; 0.96
LI et al. [45] 345 47±59
sessions
6MWT (m) ET −6 p=0.002 - PRE>POST;
−0.05
SINGER et al. [21] 15 8 weeks 6MWT (m) Tele-rehabilitation −7.8 p=0.73 - PRE>POST;
−0.10
Post-transplant
IHLE et al. [23] 60 23±5 days 6MWT (m) ET (inpatient) 45 p<0.001 p=0.214 INT>CON; 0.24
Control (outpatient
physiotherapy)
24 p<0.001
VO2peak (mL·min
−1·kg−1) ET (inpatient) 1.3 p=0.039 p=0.293 INT<CON; −0.19
Control (outpatient
physiotherapy)
2.2 p=0.005
PWR (W) ET (inpatient) 7.3 p=0 022 p=0.600 INT>CON; 0.09
Control (outpatient
physiotherapy)
4.7 p=0.070
LANGER et al. [22] 36 12 weeks 6MWT (% pred) ET 23 - p=0.008 INT>CON; 0.37
Control (PA counselling) 19 -
VO2peak (% pred) ET 16 - p=0.149 INT>CON; 0.20
Control (PA counselling) 12 -
PWR (% pred) ET 16 - p=0.093 INT>CON; 0.26
Control (PA counselling) 11 -
FULLER et al. [24] 66 14 weeks 6MWT (m) 14 weeks supervised ET 149±169 - p=0.36 INT<CON; −0.44
7 weeks supervised ET 202±72 -
GLOECKL et al. [30] 80 4 weeks 6MWT (m) ET+WBVT 83.5 p<0.001 p=0.029 INT>CON; 0.54
ET 55.2 p<0.001
PWR ET+WBVT 16.8 p<0.001 p=0.042 INT>CON; 0.38
ET 12.6 p<0.001
Continued
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TABLE 3 Continued
First author [ref.] N Duration Measure Intervention/comparison Δ (mean±SD where
reported)
Pre–post
p-value
Between group
p-value
Effect size
CANDEMIR et al. [25] 23 12 weeks ISWT (m) ET 103 p<0.001 - PRE<POST; 0.87
ESWT (min) 8 p<0.01 - PRE<POST; 1.33
MUNRO et al. [46] 36 12 weeks 6MWT (m) ET 92 p<0.001 - PRE<POST; 0.79
MAURY et al. [47] 36 12 weeks 6MWT (m) ET 129 p<0.05 - PRE<POST; 0.97
STIEBELLEHNER et al.
[48]
9 6 weeks VO2peak (mL·min
−1·kg−1) ET 1.9 p<0.05 - PRE<POST; 0.49
SCHNEEBERGER et al.
[26]
722 6 weeks 6MWT (m) ET in COPD SLTx 109±68 p<0.001 - PRE<POST; 1.60
ET in COPD DLTx 117±82 p<0.001 - PRE<POST; 1.43
ET in ILD SLTx 115±79 p<0.001 - PRE<POST; 1.46
ET in ILD DLTx 132±77 p<0.001 - PRE<POST; 1.71
ANDRIANOPOULOS et al.
[27]
24 3 weeks 6MWT (m) ET 86±77 p<0.001 - PRE<POST; 0.73
CHOI et al. [29] 4 8 weeks 6MWT (m) ET Tele-rehabilitation 71 - - PRE<POST; 0.62
VIVODTZEV et al. [28] 12 12 weeks VO2peak (L·min
−1) Home-based ET 0.13±0.22 p=0.059 - PRE<POST; 0.59
Endurance time (65% PWR)
(min)
9±12 p<0.05 - PRE<POST; 0.75
ET: exercise training; WBVT: whole body vibration training; 6MWT: 6 min walk test; ISWT: Incremental Shuttle Walk Test; ESWT: Endurance Shuttle Walk Test; VO2peak: peak oxygen
uptake; PWR: Peak Work Rate: SLTx: single lung transplant; DLTx: double lung transplant; COPD: Chronic Obstructive Pulmonary Disease; INT: intervention; CON: control; PRE:
Pre-intervention; POST: Post-intervention; UTC: unable to calculate; (Δ): change from baseline.
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However, the cohort study by LI et al. [45] found a small decrease in 6MWT distance from the time of
waiting list enrolment to the final 6MWT conducted before transplantation, after an average of 47 sessions
of pulmonary rehabilitation. Home-based exercise training demonstrated no significant change in 6MWT
distance in a pilot study [21].
Post-transplant
Six different measures of exercise capacity were used across the 12 post-transplant studies: 6MWT distance
[22–24, 26, 27, 29, 30, 46, 47], ISWT, ESWT [25], peak oxygen uptake (VO2peak) [22, 23, 28, 48], peak
work rate (PWR) [22, 23, 30], and endurance time (sustained at 65% PWR) [28]. LANGER et al. [22] found
a significant increase in 6MWT distance (% predicted) following exercise training compared to a control
group; however, there were no significant differences in VO2peak (% predicted) nor PWR (% predicted).
IHLE et al. [23] found no significant difference in the improvement of 6MWT distance, VO2peak or PWR
when inpatient rehabilitation was compared with outpatient physiotherapy. Furthermore, improvements in
6MWT distance were not significantly different between 7 and 14 weeks of supervised exercise training
[24]. GLOECKL et al. [30] showed significantly greater improvements in 6MWT distance and PWR, with the
addition of WBVT to exercise training. Four cohort studies implementing aerobic and resistance training
found statistically significant increases in either 6MWT distance [26, 46, 47] or ISWT distance [25].
STIEBELLEHNER et al. [48] showed significant gains in VO2peak after an aerobic exercise programme.
Furthermore, a pilot study [27] found a significant increase in 6MWT distance after exercise based
pulmonary rehabilitation. However, the pilot study by CHOI et al. [29] showed a 71-m improvement in
6MWT distance in four patients with either IPF or CF, but failed to conduct any statistical analysis.
QoL outcomes
The measures of QoL are presented in table 4. For the purpose of this review, QoL was operationalised as
measures encompassing HRQoL and/or psychological health.
Pre-transplant
QoL was assessed in eight of the nine pre-transplant studies using the Short Form (SF)-36 questionnaire,
which generates eight sub-scale and two summary scores (physical component summary (PCS) and
mental component summary (MCS)). Only the four studies reporting the summary scores were included
in the review. Other QOL measures included St Georges Respiratory Questionnaire (SGRQ) [45], EQ-5D
[45], Standard Gamble [45] and Beck Depression Inventory (BDI) [20]. Of the studies using the SF-36
questionnaire, GLOECKL et al. [42] found significant improvements in SF-36 PCS scores in the continuous
training but not the interval training group, whereas enhancements SF-36 MCS scores were found only
with interval training. DA FONTOURA et al. [19] found significant improvements in SF-36 PCS scores, but no
significant change in SF-36 MCS scores. Whereas, KENN et al. [44] found significant increases in both
SF-36 PCS and MCS scores overall for all disease entities. In contrast, LI et al. [45] revealed a significant
decline in SF-36 MCS, SGRQ and EQ-5D scores, along with no change in SF-36 PCS and Standard
Gamble scores from listing to immediately prior to lung transplantation.
Post-transplant
QoL was assessed in seven of the 12 post-transplant studies. Several measures were used including the
SF-36 questionnaire [23, 24, 26, 46], Hospital Anxiety and Depression Score (HADs) [22, 25, 30], SGRQ
[23, 25] and Chronic Respiratory Questionnaire (CRQ) [25, 30]. Data from three studies were excluded
from the results, as summary score data were not provided for the SF-36 [23, 46], SGRQ [23], CRQ [30]
and QoL Profile for Chronic Diseases [23] sub-scale questionnaires. LANGER et al. [22] found no significant
benefit of 12 weeks exercise training on anxiety and depression scores with a control group. FULLER et al.
[24] concluded that both 7 and 14 weeks of supervised training enhanced SF-36 PCS and MCS scores at
14 weeks, with no significant difference found between the two groups. GLOECKL et al. [30] found no
significant difference in the improvement of HADS scores between WBVT and exercise training compared
to exercise training alone. SCHNEEBERGER et al. [26] showed improvements in SF-36 PCS and MCS scores in
COPD and interstitial lung disease (ILD) patients, with no significant differences found in scores between
transplant procedures for either disease entity. CANDEMIR et al. [25] demonstrated significant increases in
HADs, SGRQ and CRQ scores following a comprehensive outpatient programme.
Clinical outcomes
Clinical outcome measures after surgery were reported in two pre-transplant studies [17, 45]. FLORIAN et al.
[17] concluded that patients with IPF who underwent exercise-based pulmonary rehabilitation had a
higher survival rate 5 years after transplant (89.9% versus 60.9%; p<0.001), a shorter length of stay in the
ICU (5 days versus 7 days; p=0.004) and hospital (20 days versus 25 days; p=0.046), along with a lower
requirement for more than 24 h invasive mechanical ventilation (IMV) (9% versus 41.6%; p<0.001),
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compared with control subjects. Cox regression models revealed that patients who completed the 12- week
exercise programme had a reduced 54% risk of death (hazard ratio0.464, 95% CI 0.222–0.970; p=0.041). In
the single-arm cohort study by LI et al. [45], the absence of control data meant it was not possible to
interpret the effect of the intervention on clinical outcome measures; however, data showed that, at the
end of hospital admission for transplantation, 79% were discharged home, 13% to inpatient rehabilitation
and 8% died. The median hospital length of stay was 18 days (range 7 to 313 days).
Safety
Adverse event reporting was poor, with only 38% of studies (four pre-transplant studies [18, 21, 42, 44]
and four post-transplant studies [24, 26, 29, 30]) mentioning adverse events. Of those, no adverse events
related to exercise training were reported over the study period.
TABLE 4 Effects of pre- and post-transplant exercise training interventions on measures of QoL
First author
[ref.] N Duration Measure
Intervention/
comparison Pre–post p-value
Between group
p-value Effect size
Pre-transplant
GLOECKL et al.
[42]
60 3 weeks SF-36 Interval ET PCS: p>0.05
MCS: p<0.05
PCS: p=0.43
MCS: p=0.066
PCS: INT<CON; −0.24
MCS: INT>CON; 0.57
Continuous ET PCS: p<0.05
MCS: p>0.05
PEHLIVAN et al.
[20]
39 8 weeks
(minimum)
BDI ET p=0.004 - PRE<POST; 0.28
DA FONTOURA
et al. [19]
31 12 weeks SF-36 ET PCS: p=0.004
MCS: p=0.113
- PCS: PRE<POST; 0.43
MCS: PRE<POST; 0.15
KENN et al. [44] 811 5–6 weeks SF-36 ET PCS: p<0.001
MCS: p<0.001
- PCS: PRE<POST; 0.22
MCS: PRE<POST; 0.64
LI et al. [45] 345 ∼16 weeks (47
±59 sessions)
SF-36 ET PCS: p=0.11
MCS: p<0.05
- PCS: PRE>POST; −0.125
MCS: PRE>POST; −0.47
SGRQ p<0.05 - PRE>POST; −0.52
SG p=0.050 - PRE>POST; −0.08
EQ-5D p<0.05 - PRE>POST; −0.48
Post-transplant
LANGER et al.
[22]
36 12 weeks HADs ET - Anxiety: p=0.812
Depression:
p=0.899
Anxiety: INT<CON; −0.36
Depression: INT<CON;
−0.09
Control (PA
counselling)
-
FULLER et al.
[24]
66 14 weeks SF-36 14 wks
supervised ET
- PCS: p=0.32
MCS: p=0.74
PCS: INT>CON; 0.11
MCS: INT<CON; −0.18
7 wks
supervised ET
-
GLOECKL et al.
[30]
80 4 weeks HADs ET+WBVT Anxiety: p=0.180
Depression: 0.247
Anxiety: p=0.174
Depression:
p=0.533
Anxiety: INT<CON; 0.33
Depression: UTC
ET Anxiety: p=0.001
Depression: 0.038
CANDEMIR et al.
[25]
23 12 weeks HADs ET Anxiety: p=0.001
Depression: p<0.01
- Anxiety: PRE<POST; 3.00
Depression: PRE<POST;
2.00
SGRQ p<0.01 - PRE<POST; 1.36
CRQ p<0.001 PRE<POST; 1.52
SCHNEEBERGER
et al. [26]
722 6 weeks SF-36 ET (COPD
SLTx)
PCS: P⩽0.001
MCS: P⩽0.01
- PCS: PRE<POST; 1.00
MCS: PRE<POST; 0.53
ET (COPD
DLTx)
PCS: P⩽0.001
MCS: P⩽0.001
PCS: PRE<POST; 0.78
MCS: PRE<POST; 0.47
ET (ILD SLTx) PCS: P⩽0.001
MCS: P⩽0.001
PCS: PRE<POST; 0.67
MCS: PRE<POST; 0.83
ET (ILD DLTx) PCS: P⩽0.001
MCS: P⩽0.001
PCS: PRE<POST; 1.00
MCS: PRE<POST; 0.67
ET: exercise training; WBVT: whole body vibration training; SLTx: single lung transplant; DLTx: double lung transplant; INT: intervention; CON:
control; SF-36: Short Form 36 Questionnaire; SGRQ: St George’s Respiratory Questionnaire; CRQ: Chronic Respiratory Questionnaire; HADS:
Hospital Anxiety and Depression Scale; VAS: Visual Analogue Scale; BDI: Beck Depression Inventory; SG: Standard Gamble; PCS: Physical
Component Summary; MCS: Mental Component Summary.
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Discussion
In this systematic review, evidence from 21 studies including 2596 patients was synthesised to examine the
effect of exercise training on exercise capacity, QoL and clinical outcomes before or after lung
transplantation. While there is evidence suggesting positive effects of exercise training interventions on these
outcomes, the current evidence is predominantly limited to non-randomised and observational studies and is
therefore of lower quality. Prior to and following transplantation, the evidence suggests that exercise training
can maintain or improve functional exercise capacity, with effects for improvements ranging from small to
large. Furthermore, the enhancements in 6MWT distance tend to exceed the minimal clinically important
difference (MCID) defined for chronic lung diseases [49–51]. Most studies demonstrate a beneficial impact
of exercise training on QoL outcomes. Data on clinical outcomes is sparse; however, it indicates a survival
benefit of exercise training, accompanied with favourable post-operative outcomes.
Exercise capacity: pre-transplant
Seven of the nine studies reported improvements in exercise capacity following completion of an exercise
programme prior to lung transplantation. Of these studies, two were inpatient (3–6 weeks) and five were
outpatient programmes (8–12 weeks), with no observable benefit of one approach over the other. The
6MWT is commonly used in pre- and post-operative evaluation and has proven beneficial in determining
the effect of therapeutic interventions, due to its prognostic value [6, 52]. It has also been found to correlate
with VO2peak in candidates for lung transplantation [53]. The improvements presented in the seven studies all
exceeded the MCID for 6MWT distance for patients with chronic lung disease, which have been reported as
>30 m for COPD [49], >22–37 m for ILD [50], and 33 m for pulmonary hypertension [51]. Currently,
evidence for the MCID in cystic fibrosis is lacking. Despite this, direct causation cannot be confirmed, due to
the lack of a no-treatment control group in eight of the nine studies.
The RCT comparing interval and continuous training did not confer any benefit of one approach over the
other, in terms of functional or maximal exercise capacity [42]. This finding agrees with that of
BEAUCHAMP et al. [54], where interval and continuous training were deemed comparable in patients with
COPD. However, interval training was associated with lower training symptoms and therefore may be used
as alternative, more tolerable method of training [42]. Of the two studies showing no improvement in
6MWT distance, the intervention implemented by LI et al. [45] was significantly longer (∼16 weeks)
compared to other pre-transplant studies (3–12 weeks) in this review [18–20, 42–44]. Therefore, this
longer time period may have resulted in greater disease progression and risk for exacerbation. It is also
important to note that a criterion for lung transplant listing is a survival prognosis of less than 2 years,
therefore maintenance of 6MWT distance pre-transplantation could be considered a positive finding, as
functional deterioration can occur rapidly during the waiting period. Indeed, the pilot study by SINGER
et al. [21] was the first to introduce home-based tele-rehabilitation prior to lung transplantation, and
demonstrated maintenance of 6MWT distance, although this could also be due to the small sample size
(n=15). Overall, the intervention [21] was well received and safe, hence, further investigation in the form
of an RCT should be conducted to determine the true effect of this novel intervention, that could confer
similar benefits to supervised exercise training, but without the financial and logistical demands.
The above findings confirm and expand those reported in the review by HOFFMAN et al. [10], in which a
significant improvement in 6MWT distance was found in four of the six studies included. Since the review
by HOFFMAN et al. [10], more observational studies have added to the evidence base; however, RCTs are
still lacking. A possible reason for the lack of RCTs in this population is that as exercise-based pulmonary
rehabilitation has become a well-recognised treatment in patients with chronic respiratory diseases [55–
57], obtaining a non-exercising control group is difficult and potentially unethical.
Exercise capacity: post-transplant
All 12 studies conducted post-transplantation reported an improvement in at least one measure of exercise
capacity. However as only one study compared exercise training to a non-exercising control group [22], it
is difficult to draw definite conclusions. Nevertheless, in this study [22] the improvement in 6MWT
distance was significantly higher in the intervention group than the control group, both at 12 weeks and
1 year. This study scored well on the quality assessment, providing robust evidence that exercise training
has a beneficial effect on functional exercise capacity, which reflects the capacity required to undertake
activities of daily living [58]. However, this evidence is restricted to the participant age range of
40–65 years highlighting a need for future RCT’s in younger lung transplant recipients [22]. It should be
highlighted that the control group in the study by LANGER et al. [22] demonstrated an improvement of
132 m over the 12-week intervention period. Thus, the natural course of recovery from lung
transplantation can result in clinically significant increases in 6MWT distance, even when additional
exercise training is not undertaken. This supports the fact that although all single-arm studies showed
significant enhancements in 6MWT distance, definite cause and effect cannot be determined.
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LANGER et al. [22] found no significant improvement in maximal exercise capacity (VO2peak (% predicted) or
PWR (% predicted)) immediately post-intervention. Despite this, VO2peak (% predicted) was 71% in the
exercise training group at 12 weeks and 78% at 1 year, which exceeds the values commonly reported in the
first year following lung transplant of 40–60% of predicted normal values [59, 60]. The higher VO2peak
(% predicted) values shown in this study may be due to only patients with an uncomplicated post-operative
period being included. Therefore, this does not represent patients having a prolonged hospital stay, who are
likely to exhibit lower exercise capacity as a result of prolonged deconditioning. In recipients 12–18 months
post-transplant, STIEBELLEHNER et al. [48] demonstrated significant improvements in VO2peak after aerobic
training; however, these values were still limited to 65% predicted. It is noted that prior to initiating the
exercise programme, patients were followed for 6 weeks and showed no significant change in VO2peak and
PWR. The comparison between the control and intervention period improves the internal validity of this
cohort study, by attempting to differentiate the effect of the training intervention from natural recovery.
Both inpatient and outpatient exercise training significantly improved VO2peak in recipients 4.5±3.2 years
following transplant [23]. Thus, exercise training is beneficial in the long-term and short-term
management of lung transplant recipients. It is known that chronic exercise limitation following lung
transplant is predominantly due to impaired oxidative capacity of skeletal muscle which is exacerbated by
immunosuppressive medications [11], thus optimising peripheral muscle function is an important goal of
exercise training [61]. GLOECKL et al. [30] concluded that WBVT may be used as a complimentary therapy
to exercise training, demonstrating further enhancements in exercise capacity. This is thought to be due to
the mechanical vibration eliciting neuromuscular adaptations.
The previous systematic review looking at exercise training interventions post-transplantation [16] showed
a positive effect on exercise capacity (maximal or functional) in four studies. This review expands
significantly on those findings, with 12 studies exhibiting improvements in at least one measure of exercise
capacity. In addition to strengthening the evidence base, this review includes studies examining the effect
of different modes, doses and settings of exercise training on exercise capacity.
Quality of life: pre- and post-transplant
The most common measure of QoL was the SF-36 questionnaire, which is a global measure of HRQoL
[62]. Prior to transplantation, improvements in SF-36 PCS scores ranged from 2 to 4 points and MCS
from 2 to 10 points. Currently, the interpretation of changes in SF-36 scores is challenging, as the MCID
for lung transplant candidates has not yet been defined. General recommendations for the tool suggest a
MCID of four points [2], and a study conducted in IPF patients proposed a MCID of >2–4 units for PCS
and MCS scores [63].
Notably, interval training was associated with a significant improvement in SF-36 MCS scores over time,
which may be partly attributed to the lower training symptoms (dyspnoea and leg fatigue) associated with
this mode of training [42, 64]. Although LI et al. [45] found no improvement in QoL scores, measures
reflecting physical function (SF-36 PCS, SGRQ activity domain) were better preserved than other HRQoL
measures (e.g. SF-36 MCS). Comparison of HRQoL in lung transplant candidates to normative
populations has typically shown greatest impairment in physical function rather than mental health
domains [37], highlighting the importance of maintaining or improving this aspect.
After transplant, LANGER et al. [22] found no significant difference in HADS scores between the exercise
training and control group. This may be related to low baseline scores indicative of sub-clinical levels of
anxiety (intervention=5.0±3.4 versus control=7.1±4.1) and depression (3.8±3.4 versus 4.5±3.5) [65]. As
such, there was little scope for improvement in this outcome domain, particularly in the intervention
group. This is supported by the significant improvement in HADS scores reported by CANDEMIR et al. [25],
in which baseline scores were 10±1 and 9±1 for anxiety and depression, respectively.
The improvements in the SF-36 PCS and MCS scores following exercise training [24, 26] well exceeded
the estimated MCID (>2–3 units) proposed for lung transplant recipients [66]. A multi-centre study [67]
exploring the trajectory of QoL from pre-transplant to 1 year post-transplant without exercise training,
reported significant gains in PCS score (+10.9), demonstrating a natural course of physical QoL
improvement. This is likely due to marked improvements in pulmonary function, resulting in reduced
symptom burden and enhancing the ability to complete everyday activities. However, in this observational
study MCS remained unchanged. This indicates that exercise training has a beneficial impact on this QoL
component, as improvements in this domain were evident in studies implementing exercise training [24,
26]. Since the review by WICKERSON et al. [16] which incorporated one study evaluating QoL, further
studies have shown a beneficial impact of exercise training on QoL [22, 24–26, 30], adding to this
preliminary evidence. Besides survival, improving QoL is one of the key objectives of lung transplantation,
hence interventions that can enhance QoL following the procedure are of great importance.
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Clinical outcomes
The evidence pertaining to exercise training and post-transplant clinical outcomes is sparse. Since the last
systematic review [10] however, a quasi-experimental study has concluded that pulmonary rehabilitation
conducted before lung transplantation halved the risk of mortality and reduced the risk of prolonged ICU
and hospital stay [17]. This study [17] is limited by its design, as lack of randomisation may have led to
potential selection bias. Additionally, the study [17] only included those with IPF, so findings cannot be
extrapolated to all transplant patients.
Safety of exercise training
Limited studies (38%) report data on safety; however, in those that did, no adverse events related to
exercise training were reported. This highlights the inconsistent and inadequate reporting of safety in
exercise training trials in lung transplant patients, a population that has an increased risk for
complications and comorbidities.
Strengths and weaknesses of this review
To our knowledge, this is the first systematic review to synthesise the effects of exercise training in both
lung transplant candidates and post-transplant recipients. The review was conducted in a rigorous manner
in accordance with PRISMA guidelines [32]. Specific search terms were used to identify appropriate
articles and bias was minimised through independent screening by two investigators, using pre-defined
criteria. Limitations to this review include the lack of RCTs (five out of 21 studies) and absence of a
comparator group or a priori sample size calculations in most studies. As such, it was not possible to
perform a meta-analysis due to multiple sources of heterogeneity, including type of exercise training
intervention, study design and outcome measures. Additionally, participants across studies varied in
underlying respiratory disease and age. Currently, there is little evidence on the effect of exercise training
on clinical outcomes; however, the single study included does show a survival benefit [17]. Additional
research is needed to establish the efficacy of home-based exercise training interventions. Future studies
implementing exercise training should ensure consistent reporting of safety outcomes (e.g. adverse events),
as this information is important for decision making by regulators, policy makers and health-care
professionals. Findings should be interpreted with caution due to the single-arm study designs
implemented in most studies, limiting the ability to establish definite cause and effect. Nevertheless, the
review represents the best available overview of the current evidence base for exercise training pre- and
post-lung transplantation.
Conclusions
Both inpatient and outpatient exercise training appears to be beneficial for patients before and after lung
transplantation. In general, most studies indicated exercise training interventions to be effective in
improving exercise capacity and QoL. Accordingly, exercise training appears valuable in the management
of patients both listed for transplantation and following lung transplant surgery.
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